Aesculin inhibits matrix metalloproteinase-9 expression via p38 mitogen activated protein kinase and activator protein 1 in lipopolysachride-induced RAW264.7 cells
- 1 November 2012
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 14 (3), 267-274
- https://doi.org/10.1016/j.intimp.2012.07.013
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology & Medicine, 2010
- A cytokine-mediated link between innate immunity, inflammation, and cancerJCI Insight, 2007
- Matrix metalloproteinases and the regulation of tissue remodellingNature Reviews Molecular Cell Biology, 2007
- IN SILICO MODELS OF ACUTE INFLAMMATION IN ANIMALSShock, 2006
- Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 CellsThe Journal of Immunology, 2004
- Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potentialThe FASEB Journal, 2004
- Differential Regulation of Lipopolysaccharide-Induced Monocyte Matrix Metalloproteinase (MMP)-1 and MMP-9 by p38 and Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein KinasesThe Journal of Immunology, 2003
- Aesculin Possesses Potent Hypouricemic Action in Rodents but is Devoid of Xanthine Oxidase/Dehydrogenase Inhibitory ActivityPlanta Medica, 2002
- LPS induction of gene expression in human monocytesCellular Signalling, 2001
- SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000